Bachri Houda, Essangri Hajar, El Bahaoui Nezha, Benkabbou Amine, Mohsine Raouf, Majbar Anass Mohammed, Souadka Amine
Surgical Oncology Department, National Institute of Oncology, Mohammed Vth University in Rabat, Rabat 10100, Morocco.
Gynecology oncology Department, Royal London Hospital, Barts NHS Health, London SE18 6EY, United Kingdom.
World J Methodol. 2023 Sep 20;13(4):259-271. doi: 10.5662/wjm.v13.i4.259.
Quality of life (QoL) outcomes are a focal endpoint of cancer treatment strategies.
To externally validate the Moroccan Arabic version of the European Organization for Research and Treatment of Cancer (EORTC) QoL Questionnaire (QLQ) for colorectal cancer (CRC) patients (CR29).
Both Moroccan Arabic modules of QLQ-CR29 and QLQ-C30 were administered to Moroccan CRC. Psychometric properties were retested by measuring Cronbach's alpha coefficient for reliability and Intraclass correlation coefficient (ICC) to examine test-retest reproducibility. The multitrait-scaling analysis was performed to demonstrate the validity of the instrument and known-groups comparison was used to test the score's ability to discriminate between different groups of patients.
In total, 221 patients were included in our study and 34 patients completed the questionnaire twice. The Urinary Frequency scale and Stool Frequency scale had good internal consistency with alpha Cronbach coefficients of 0.79 and 0.83 respectively, while the same coefficients were moderately lower for the Blood and Mucus in Stool scale (0.61) and the Body Image scale (0.67). The ICCs ranged from 0.88 to 1 indicating good to excellent reproducibility. In multitrait scaling analyses, the criterion for item convergent and divergent validity was satisfactory. The known-group comparison showed statistically significant differences between patients according to age, gender, stoma status, tumor location, and radiotherapy.
The Moroccan Arabic version of the EORTC QLQ-CR29 is a valid and reliable tool that can be used safely for research and clinical purposes in Moroccan CRC patients.
生活质量(QoL)结果是癌症治疗策略的一个重点终点。
对外验证欧洲癌症研究与治疗组织(EORTC)生活质量问卷(QLQ)摩洛哥阿拉伯语版用于结直肠癌(CRC)患者(CR29)的有效性。
将QLQ - CR29和QLQ - C30的摩洛哥阿拉伯语模块施用于摩洛哥CRC患者。通过测量Cronbach's alpha系数来重新测试信度的心理测量特性,并使用组内相关系数(ICC)来检验重测信度。进行多特质量表分析以证明该工具的效度,并使用已知组比较来测试该分数区分不同患者组的能力。
我们的研究共纳入221例患者,34例患者完成了两次问卷。尿频量表和排便频率量表具有良好的内部一致性,Cronbach's alpha系数分别为0.79和0.83,而粪便中带血和黏液量表(0.61)及身体形象量表(0.67)的相同系数略低。ICC范围为0.88至1,表明具有良好至优秀的重测信度。在多特质量表分析中,项目收敛效度和区分效度的标准令人满意。已知组比较显示,根据年龄、性别、造口状态、肿瘤位置和放疗情况,患者之间存在统计学上的显著差异。
EORTC QLQ - CR29的摩洛哥阿拉伯语版是一种有效且可靠的工具,可安全地用于摩洛哥CRC患者的研究和临床目的。